Updated on 2023/11/06

写真a

 
KANAZAWA Reiko
 
Organization
Graduate School of International Development Department of International Development and Cooperation Associate professor
Graduate School
Graduate School of International Development
Title
Associate professor
Contact information
メールアドレス

Degree 3

  1. Ph.D. Medical History ( 2019.3 ) 

  2. M.A. Modern History ( 2014.9 ) 

  3. B.A. Early Modern/Modern European History ( 2012.6 ) 

Research Interests 9

  1. Contemporary history of AIDS

  2. Pharmaceutical history

  3. International development financing

  4. Modern Indian History and Politics

  5. HIV/AIDS Policy and Prevention

  6. International drug control

  7. Contemporary history

  8. International development

  9. Global health

Current Research Project and SDGs 1

  1. Boundaries of Addiction, Treatment and Disease: Global Drugs Governance from Post-war to AIDS

Research History 6

  1. Brocher Foundation   Researcher   Visiting Researcher

    2022.3

      More details

    Country:Switzerland

    Notes:Visiting researcher at the Brocher Foundation in Hermance, Switzerland (four weeks).

  2. University of Edinburgh   College of Medicine and Veterinary Medicine, Usher Institute   Researcher   Research Fellow Global Health Governance

    2019.9 - 2021.8

      More details

    Country:United Kingdom

    Notes:Research Fellow Global Health Governance in the Beyond Global strand of the Centre for Biomedicine, Self and Society (CBSS-Wellcome Trust funded) directed by Professor Sarah Cunningham-Burley and Professor Steve Sturdy.

  3. Shanghai University   Musto Center for Drug Policy Studies   Researcher

    2019.1 - 2019.9

      More details

    Country:China

    Notes:Based in Shanghai at the Musto Center for Drug Policy Studies (MCDPS) and the Center for the History of Development (CHD) at Shanghai University. Employed under the Centre for the Social History of Health and Healthcare (CSHHH) at the University of Strathclyde under Wellcome Trust grant "The Shanghai Initiative: Medical Humanities futures in the UK and Asia"

  4. Rockefeller Archive Center   Researcher   Visiting Researcher

    2017.1 - 2017.2

      More details

    Country:United States

    Notes:Visiting researcher under Rockefeller Archive Center Grant-in-Aid 2017 Programme (six week stay).

  5. University of Hong Kong   Centre for the Humanities and Medicine   Researcher   Visiting Researcher

    2016.11 - 2016.12

      More details

    Country:Hong Kong

    Notes:Research stay under Professor Robert Peckham and Dr Ria Sinha from November to December 2016 (six weeks).

  6. Jawaharlal Nehru University   Centre for Social Medicine and Community Health   Researcher   Visiting Researcher

    2016.7 - 2017.5

      More details

    Notes:Research affiliation under Professor Mohan Rao at JNU Centre for Social Medicine and Community Health, July 2016-May 2017

▼display all

Education 3

  1. University of Exeter (UK)   History Department   Medical History

    2015.1 - 2019.3

      More details

    Country: United Kingdom

  2. University of Warwick (UK)   Department of History   Modern History

    2013.9 - 2014.9

      More details

    Country: United Kingdom

  3. Carleton College   Department of History   Early Modern/Modern European History

    2008.9 - 2012.6

      More details

    Country: United States

Professional Memberships 4

  1. Japanese Association for South Asian Studies (JASAS)

  2. Alcohol and Drugs History Society (ADHS)

  3. Society for the Social History of Medicine (SSHM)

  4. British Association for South Asian Studies (BASAS)

Committee Memberships 6

  1. GSID Research Ethics Committee   Chairperson  

    2023.4 - 2024.3   

  2. Academic Affairs Committee   Committee member  

    2023.4 - 2024.3   

  3.   GSID Research Ethics Committee  

    2022.6   

  4.   Departmental Contact for Harassment Consultation  

    2022.4 - 2023.3   

  5.   GSID Research Ethics Committee Start-up Working Group  

    2022.4 - 2022.6   

  6.   Entrance Examination Committee  

    2021.9 - 2023.3   

▼display all

Awards 3

  1. Distinction in Major and Thesis

    Carleton College, Department of History  

  2. PhD viva: pass no corrections

    University of Exeter  

  3. Distinction

    University of Warwick  

 

Papers 11

  1. Pandemic Responses and the Strengths of Health Systems: A Review of Global AIDS Historiography in Light of COVID-19 Invited Reviewed International journal

    Reiko Kanazawa

    ISIS   Vol. 114 ( S1 )   2023.9

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:University of Chicago Press  

    DOI: https://doi.org/10.1086/727718

    DOI: https://doi.org/10.1086/727718

    Other Link: https://isiscb.org/special-issue-on-pandemics/essay.html?essayID=16

  2. Pricing Retrovir: Wellcome PLC and the Role of Pharmaceutical Companies in the Global AIDS Crisis, 1986 to 1991 Reviewed

    Reiko Kanazawa

    Journal of the History of Medicine and Allied Sciences     2022.7

     More details

    Authorship:Lead author, Last author, Corresponding author   Publishing type:Research paper (scientific journal)  

    DOI: https://doi.org/10.1093/jhmas/jrac027

    Other Link: https://academic.oup.com/jhmas/advance-article-abstract/doi/10.1093/jhmas/jrac027/6628706

  3. Governing Drugs Globally: The World Health Organization and Public Health in International Drug Control Reviewed International journal

    Kanazawa R.

      Vol. 36 ( 1 ) page: 5 - 44   2022.3

     More details

    Authorship:Lead author, Last author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:Social History of Alcohol and Drugs  

    This article charts the public health argument in international drug control through the activities of the World Health Organization (WHO), an underaddressed actor in histories of global drug policy. From the postwar period to the 1980s, the aims of international drug control and international health became deeply interlinked. This realization dawned slowly on both WHO and United Nations drug agencies as they faced complex and urgent problems without clear answers. WHO was most influential in the years leading up to and just after the Single Convention, critically establishing that people dependent on drugs were patients. In the 1970s, the agency’s role declined due to the United States declaring its “war on drugs” foreign policy and the rise of pharmaceutical lobbying. By the 1980s, WHO found itself on the front lines of the HIV crisis through injecting drug use, constructing ad hoc policy and initiating interventions in collaboration with country governments and health professionals.

    DOI: 10.1086/718332

    Scopus

  4. Pandemic Responses and the Strengths of Health Systems: A Review of Global AIDS Historiography in Light of COVID-19

    Kanazawa, R

    ISIS   Vol. 114 ( S1 ) page: S162 - S205   2023.9

     More details

    Publisher:Isis  

    This paper surveys the historiography of the global response to HIV/AIDS. Since 1981, when the disease was first identified, there have been great strides in the medical and biological sciences in understanding the impact of the new virus on the human immune system. Although there is still no successful vaccine, antiretroviral (ART) treatment continues to improve the likelihood of HIV-positive people living long and healthy lives. We have also seen a few exciting cases of full recovery, which will allow scientists to explore new avenues towards a cure. Yet the AIDS pandemic is by no means over: 40 million have died and over 35 million individuals still live with HIV. More importantly, as historians and scholars in the humanities and social sciences have been pointing out since the early 1980s, HIV brought to light how non-medical factors play a critical role in a successful disease response. As the global community faces the aftermath of a new pandemic, it is timely to examine how broader social, economic, political, and cultural factors influence individual experiences of disease at local, national, international, and global scales. This essay examines how scholars have written historically about the HIV pandemic, using a variety of methods and approaches: from traditional histories of medicine to anthropologies of development. While HIV has sparked a massive corpus of historical reflection from a variety of disciplines, its contemporaneity means that “global AIDS historiography” cannot yet be described as a cohesive academic conversation. Yet what unites the scholarship, this essay argues, is its use of HIV to examine how and why post-war social and economic systems have achieved health objectives for some populations and not others.

    DOI: 10.1086/726985

    Web of Science

    Scopus

  5. Pricing Retrovir: Wellcome PLC and the Role of Pharmaceutical Companies in the Global AIDS Crisis, 1986 to 1991

    Kanazawa, R

    JOURNAL OF THE HISTORY OF MEDICINE AND ALLIED SCIENCES   Vol. 77 ( 4 ) page: 425 - 452   2022.11

     More details

    Language:English   Publisher:Journal of the History of Medicine and Allied Sciences  

    In spring 1987, British pharmaceutical company Wellcome PLC released azidothymidine (AZT) sold under trade name Retrovir, the first successful treatment for AIDS. In the context of a global public health emergency and with no competing products, Wellcome invested heavily in upfront costs to bring Retrovir to market, reflected in the original launch price of $188 (US dollars), applied to all other markets. Retrovir subsequently faced backlash in the United States for its high cost and Wellcome's profits became a target of debates about prescription drugs in the American healthcare system. As a result, the company agreed to two price reductions within the first two years of market release. Events in the US had global impact, discouraging the company from providing AZT via commercial channels in African countries. Drawing from new archival material, this article explores how Retrovir's pricing reflected the uncertainties of the global AIDS crisis as well as the unique risks Wellcome faced as a foreign company in its most important market of the US. It argues that, contrary to critical opinion, Wellcome's pricing of Retrovir did reflect an underlying principle regarding the appropriate role of for-profit research-intensive pharmaceutical companies during an unprecedented pandemic.

    DOI: 10.1093/jhmas/jrac027

    Web of Science

    Scopus

    PubMed

  6. Review of Sandra Bärnreuther, Substantial Relations: Making Global Reproductive Medicine in Postcolonial India (Ithaca and London: Cornell University Press, 2021) Invited

    Reiko Kanazawa

    Social History of Medicine     2022.5

     More details

    Authorship:Lead author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)  

    DOI: https://doi.org/10.1093/shm/hkac027

    DOI: https://doi.org/10.1093/shm/hkac027

    Other Link: https://academic.oup.com/shm/advance-article/doi/10.1093/shm/hkac027/6585579?guestAccessKey=b0609943-b8af-47c3-946f-bb772e3d4bcd

  7. Substantial Relations: Making Global Reproductive Medicine in Postcolonial India Invited International journal

    Kanazawa, R

    SOCIAL HISTORY OF MEDICINE     2022.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1093/shm/hkac027

    Web of Science

  8. Remembering Edinburgh’s AIDS Experience during COVID-19 Invited

    Reiko Kanazawa

    The Polyphony     2021.7

     More details

    Authorship:Lead author, Corresponding author   Language:English   Publishing type:Research paper (conference, symposium, etc.)  

    Other Link: https://thepolyphony.org/2021/07/05/remembering-edinburgh-aids-exp/

  9. Positioning AIDS Activism in India: Civil Society Responses Between Development Aid, Global Health and the State, 1989 to 2001 Reviewed

    Reiko Kanazawa

    Social History of Medicine   Vol. 34 ( 1 ) page: 23 - 45   2021.2

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)  

    DOI: https://doi.org/10.1093/shm/hkz090

    DOI: https://doi.org/10.1093/shm/hkz090

  10. Disease in a Debt Crisis: Financing Global Health, Development and AIDS between WHO and World Bank, 1978–87 Reviewed

    Reiko Kanazawa

    Medical History   Vol. 64 ( 3 ) page: 303 - 324   2020.6

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)  

    DOI: doi:10.1017/mdh.2020.17

  11. The Ford Foundation’s early involvement in global AIDS and grants to Indian AIDS NGOs Invited

    Reiko Kanazawa

    Rockefeller Archive Center Research Reports     2017.1

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (other academic)  

▼display all

Books 1

  1. Boundaries of Addiction, Treatment and Disease: Global Drugs Governance from Post-war to AIDS Reviewed

    ( Role: Sole author)

    McGill-Queen's University Press 

     More details

    Language:English Book type:Scholarly book

Presentations 10

  1. Opiate raw materials, state-owned enterprises and postcolonial development: the case of the Burma Pharmaceutical Industry (BPI), 1957-2021 Invited

    金澤玲子

    Drugs and Empire: Twenty Years On  2023.12.7  Shanghai University

     More details

    Event date: 2023.12

    Language:English   Presentation type:Symposium, workshop panel (nominated)  

    Venue:Shanghai   Country:China  

  2. Navigating Development Financing in the Waning Cold War: India, World Bank and Japan in Economic Liberalisation, 1981-1991

    Reiko Kanazawa

    Modern Japanese History Workshop  2022.2.11  University of Tokyo

     More details

    Event date: 2022.2

    Language:English   Presentation type:Oral presentation (general)  

    Venue:Zoom-University of Tokyo   Country:Japan  

    Other Link: https://sites.google.com/site/modernjapanhistoryworkshop/home

  3. “Japan and Development Financing in the Waning Cold War: Aid, Trade and Economic Policy in India”

    Reiko Kanazawa

    Japanese Association for South Asian Studies 34th Annual Conference 

     More details

    Event date: 2021.10

    Language:Japanese   Presentation type:Oral presentation (general)  

    Venue:Zoom  

  4. Remaking Development Financing: Thinking through Japan-India Relations beyond Strategic Partnership Invited International conference

    Reiko Kanazawa

    IAAPS Distinguished Lecture series  2022.9.18  Indian Association for Asian and Pacific Studies

     More details

    Event date: 2022.9

    Language:English   Presentation type:Oral presentation (invited, special)  

    Venue:Online   Country:India  

  5. Pricing Retrovir: Shifting the Dialogue on Drug Access from Safety to Cost in the First Successful AIDS Treatment (1987-1991) International conference

    Reiko Kanazawa

    Health, Body, and the Profit Motive: Medicine as a Business in History  2021.11.20  Historians' Workshop

     More details

    Event date: 2021.11

    Language:English   Presentation type:Oral presentation (general)  

    Venue:Zoom  

  6. Addiction Consultants and Pharmacology Experts: WHO and International Drug-Health Diplomacy in Thailand and India, 1961-1980 Invited

    Reiko Kanazawa

    De-Centring Science Diplomacy: Cases from Asia Mini-Workshops  2021.4.16  Commission on Science, Technology and Diplomacy, Division on History of Science and Technology

     More details

    Event date: 2021.1 - 2021.5

    Language:English   Presentation type:Oral presentation (general)  

    Venue:Zoom   Country:United Kingdom  

    Other Link: https://sciencediplomacyhistory.org/2021/07/08/de-centring-science-diplomacy-cases-from-asia-mini-workshops/

  7. ‘How did HIV through injecting drugs become global health priority? Opioid substitution in India

    Reiko Kanazawa

    Alcohol and Drugs History (ADHS) Society Annual Conference 2019  Shanghai University

     More details

    Event date: 2019.6

    Language:English   Presentation type:Oral presentation (general)  

    Venue:David Musto Center for Drug Policy Studies   Country:China  

  8. India and World Bank: Mutual Goals within Broader Politics, 1983 to 1991 International conference

    Reiko Kanazawa

    Political Studies Association 69th Annual International Conference  Nottingham Trent University

     More details

    Event date: 2019.4

    Language:English   Presentation type:Oral presentation (general)  

    Venue:Nottingham Trent University   Country:United Kingdom  

    Other Link: https://www.psa.ac.uk/psa/news/psa-2019-annual-conference-highlights

  9. The Ford Foundation’s Relationship with Indian AIDS NGOs from 1990 in the Context of Health Sector Reforms

    Reiko Kanazawa

    Visiting Scholar Seminar  Centre for Social Medicine and Community Health

     More details

    Event date: 2017.3

    Language:English   Presentation type:Oral presentation (general)  

    Venue:Jawaharlal Nehru University   Country:India  

  10. Historicising AIDS in India: Complex Secondary Literature International conference

    Reiko Kanazawa

    Visiting Scholar and Graduate Student Programme  2016.12.4  Centre for the Humanities and Medicine

     More details

    Event date: 2016.12

    Language:English   Presentation type:Oral presentation (general)  

    Venue:University of Hong Kong   Country:Hong Kong  

▼display all

Other research activities 1

  1. Scotland in the Global: HIV through Injecting Drugs and Beyond

    2021.4

     More details

    A Mini Workshop Series held in April 2021, UEdinburgh, CBSS, Beyond Global theme: links to workshop recordings

    https://www.ed.ac.uk/usher/biomedicine-self-society/centre-news/scotland-in-the-global-hiv-through-injecting-drugs

Research Project for Joint Research, Competitive Funding, etc. 7

  1. Brocher Foundation Research Residency

    2022.3

      More details

    Grant type:Competitive

  2. Rockefeller Archive Center Grant-in-Aid Programme

    2017.1 - 2017.2

    Reiko Kanazawa

      More details

    Grant type:Competitive

    Grant amount:\43660

  3. Internal share of Usher funds for Tokyo archival research (cancelled due to COVID)

    2021.2

      More details

    Grant type:Competitive

    Grant amount:\22400

  4. Internal share of funds for Geneva fieldwork (cancelled due to COVID)

    2020.4

      More details

    Grant type:Competitive

  5. Interview fieldwork and Hindi language training

    2016.6

    Reiko Kanazawa

      More details

    Grant type:Competitive

    Grant amount:\117020

  6. Fieldwork and Hindi language training budget

    2015.9

    Reiko Kanazawa

      More details

    Grant amount:\295700

  7. Research travel grant

    2015.9

    Reiko Kanazawa

      More details

    Grant amount:\60670

▼display all

KAKENHI (Grants-in-Aid for Scientific Research) 2

  1. Theorizing Japanese Global Health Diplomacy: Exchanging Funds, Technology and/or Values?

    Grant number:23K12428  2023.4 - 2027.3

    Grants-in-Aid for Scientific Research  Grant-in-Aid for Early-Career Scientists

      More details

    Authorship:Principal investigator 

    Grant amount:\1950000 ( Direct Cost: \1500000 、 Indirect Cost:\450000 )

  2. Re-imagining Development Financing: Negotiating Structural Adjustment and Economic Liberalisation between Japan, India and World Bank, 1981-1991

    Grant number:22K20160  2022.8 - 2024.3

    Grants-in-Aid for Scientific Research  Grant-in-Aid for Research Activity Start-up

      More details

    Authorship:Principal investigator 

    Grant amount:\2080000 ( Direct Cost: \1600000 、 Indirect Cost:\480000 )

 

Social Contribution 1

  1. Carleton College Alumni Admissions Representative (AAR)

    Carleton College  2022.6

     More details

    Audience: High school students, College students, General

    Type:Other

Media Coverage 2

  1. Points Interview: Dr Reiko Kanazawa Internet

    Alcohol and Drugs History Society; American Institute of the History of Pharmacy  Points  https://pointshistory.com/2022/05/05/reiko-kanazawa/  2022.5

     More details

    Author:Myself 

  2. BASAS GEC Researcher’s Corner: Reiko Kanazawa Internet

    British Association for South Asian Studies  https://www.basas.org.uk/gec-researchers-corner/reiko-kanazawa/  2021.2